Industry Partner Program

Industry Partner Program now available!

The APLAR 2026 official program is scheduled in the South Korea time zone (UTC+9). To check the program times in your location, use a time zone converter.

As more information becomes available – this page will be updated so please make sure to check back regularly.

Program is best viewed on a desktop or large landscape screen.

Thu 29 Oct
Workshop Day 2
Fri 30 Oct
Congress Day 1
Sat 31 Oct
Congress Day 2
Sun 1 Nov
Congress Day 3

	Plenary / Concurrent 1	Concurrent 2	Concurrent 3	Concurrent 4
0800-1500	Refer to main program
1500-1700	Pre-congress Industry workshop 1 Title coming soon	Pre-congress Industry workshop 2	Pre-congress Industry workshop 3	Pre-congress Industry workshop 4
1500-1700	Sponsored by AbbVie View Information	Position may be vacant. Enquire now.	Position may be vacant. Enquire now.	Position may be vacant. Enquire now.
1700-1930	Refer to main program

	Plenary / Concurrent 1	Concurrent 2	Concurrent 3	Concurrent 4
0700-1025	Refer to main program
1025-1125	Morning symposium 1 Title coming soon	Morning symposium 2 Belimumab: 15 Years of Changing the Lupus Treatment Paradigm	Morning symposium 3 Title coming soon	Morning symposium 4 Title coming soon
1025-1125	Sponsored by Celltrion View Information	Sponsored by GSK View Information	Sponsored by AbbVie View Information	Sponsored by Viatris View Information
1125-1250	Refer to main program
1250-1420		Lunch symposium 1	Lunch symposium 2 Title coming soon	Lunch symposium 3
1250-1420		Sponsored by UCB Agenda coming soon	Sponsored by Boehringer Ingelheim Agenda coming soon	Position may be vacant. Enquire now.
1420-1730	Refer to main program
1730-1825	Evening symposium 1 Tacrolimus strategy for Autoimmune real-world in Rheumatic Disease	Evening symposium 2 Title coming soon	Evening symposium 3 The significance of IL-6 signal blocking in autoimmune diseases including RA	Evening symposium 4 Therapeutic targeting of IL-6 and IL-1 pathways in autoinflammatory and autoimmune rheumatic diseases
1730-1825	Sponsored by Astellas Pharma Korea Inc. Agenda coming soon	Sponsored by Novartis Agenda coming soon	Sponsored by Chugai Pharmaceutical / JW Pharmaceutical Agenda coming soon	Sponsored by R-Pharm Group Agenda coming soon

	Plenary / Concurrent 1	Concurrent 2	Concurrent 3	Concurrent 4
0700-1025	Refer to main program
1025-1125	Morning symposium 5 Crossroads of Inflammation: What Advances in PsA/SpA Mean for Clinical Practice	Morning symposium 6 From Inflammation to Impact: Early Treatment Strategies in Spondyloarthritis	Morning symposium 7 Title coming soon	Morning symposium 8 Shifting the Trajectory: Understanding the Implications of an early subcutaneous application of Methotrexate
1025-1125	Sponsored by Johnson & Johnson View Information	Sponsored by UCB View Information	Sponsored by AbbVie Agenda coming soon	Sponsored by Medac View Information
1125-1250	Refer to main program
1250-1420		Lunch symposium 4 From Evidence to Confidence: Real-world Clinical Experience with Biosimilars in Europe	Lunch symposium 5 Polymyalgia Rheumatica: From Diagnosis to Long-Term Disease Control – Current Recommendations and Unmet Needs	Lunch symposium 6
1250-1420		Sponsored by Samsung Bioepis Agenda coming soon	Sponsored by Novartis Agenda coming soon	Position may be vacant. Enquire now.
1420-1730	Refer to main program
1730-1825	Evening symposium 5 Latest Evidence on Methotrexate and JAK Inhibitors	Evening symposium 6	Evening symposium 7	Evening symposium 8
1730-1825	Sponsored by Eisai Agenda coming soon	Position may be vacant. Enquire now.	Position may be vacant. Enquire now.	Position may be vacant. Enquire now.
1900-Late	Refer to main program